Recent Events & Catalysts
INCY (INCY) — real, dated facts. Not a claim about what caused any single day's price move.
News
Incyte (INCY): Buy, Sell, or Hold Post Q1 Earnings?
Yahoo · today
A Fresh Look At Syndax Pharmaceuticals
SeekingAlpha · 1d ago
Barclays Maintains Overweight on Incyte, Raises Price Target to $134
Benzinga · 1d ago
Sector Update: Healthcare Stocks Advance Late Afternoon
Yahoo · 2d ago
Own Regeneron For Biotech Growth? Incyte Is Making Its Case.
Yahoo · 2d ago
Incyte (INCY) Could Be 8% Overvalued As Latarcibart Moves Into Phase 3
Yahoo · 2d ago
How Investors May Respond To Incyte (INCY) Latarcibart Data In Von Willebrand Disease Prophylaxis
Yahoo · 2d ago
Incyte Says Early Data Points To Promise For Once-Monthly Preventive Treatment For Inherited Blood Disorder
Yahoo · 2d ago
SEC Filings (90 days)
Other events, Financial statements and exhibits
Filed 2026-07-06 · 10d ago
Other events
Filed 2026-06-22 · 24d ago
Submission of matters to a vote of security holders
Filed 2026-06-09 · 37d ago
Other events
Filed 2026-06-08 · 38d ago
Results of operations (earnings release)
Filed 2026-04-28 · 79d ago · Material
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.